Controlling antibiotic resistance in the ICU: different bacteria, different strategies

Louis B Rice1

  • 1Louis Stokes Cleveland VA Medical Center and Case Western Reserve University School of Medicine, Cleveland, OH 44106, USA. louis.rice@med.va.gov

Insights

Hospitals aim to curb antimicrobial resistance with strategies like infection control and antibiotic stewardship. However, data on the effectiveness of these methods in intensive care units remain limited.

Area of Science:

  • Infectious Diseases
  • Critical Care Medicine
  • Pharmacology

Background:

  • Antimicrobial resistance is a significant threat in intensive care units (ICUs).
  • Hospitals are implementing various strategies to combat this growing problem.
  • Effective control of antimicrobial resistance is crucial for patient outcomes.

Purpose of the Study:

  • To outline strategies hospitals use to reduce antimicrobial resistance in ICUs.
  • To highlight the theoretical benefits and limitations of these control measures.
  • To identify the need for better data on the efficacy of resistance control strategies.

Main Methods:

  • Review of current hospital strategies for antimicrobial resistance reduction.
  • Analysis of infection control practices.
  • Examination of antibiotic stewardship programs, including formulary adherence, prior approval, duration limits, and drug rotation.

Main Results:

  • Multiple strategies are employed, including infection control, formulary adherence, prior antibiotic approval, therapy duration limits, and scheduled antibiotic rotation.
  • Each strategy presents theoretical advantages and disadvantages.
  • There is a scarcity of robust data evaluating the real-world effectiveness of these interventions in controlling antimicrobial resistance.

Conclusions:

  • Hospitals are actively developing multifaceted approaches to mitigate antimicrobial resistance in ICUs.
  • Despite theoretical benefits, the clinical efficacy of these strategies requires further investigation.
  • More research is needed to provide evidence-based guidance for antimicrobial resistance control in critical care settings.

Related Concept Videos

Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Microbiota Modulation by Antibiotics01:21

Microbiota Modulation by Antibiotics

Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Antibiotic Selection01:45

Antibiotic Selection

Researchers use antibiotic resistance genes to identify bacteria that possess a plasmid containing their gene of interest. Antibiotic resistance naturally occurs when a spontaneous DNA mutation creates changes in bacterial genes that eliminate antibiotic activity. Bacteria can share these new resistance genes with their offspring and other bacteria. The overuse and misuse of antibiotics have created a public health crisis, as resistant and multi-resistant bacteria continue to develop.Antibiotic...
Biological Methods for Microbial Control01:28

Biological Methods for Microbial Control

Biological agents offer an effective means of controlling microbial growth by leveraging natural processes like predation, competition, and the secretion of antimicrobial substances.Predatory bacteria such as Bdellovibrio species target and kill pathogens like Salmonella and E. coli. They are widely used in poultry farms to control infections. Myxococcus species help combat plant-pathogenic fungi. These naturally occurring predators serve as eco-friendly alternatives to chemical pesticides and...